{"status":"success","data":{"title":"Hyperkalemia","slug":"hyperkalemia","tags":["insulin","albuterol","furosemide","sodium bicarbonate","Kayexalate","calcium gluconate"],"collection":["Endocrinology","Metabolic","Critical Care"],"content":"<h1 id=\"hyperkalemia\">Hyperkalemia</h1>\n<p><strong>Potassium regulation</strong></p>\n<ul>\n<li><strong>Internal K shift:</strong> modulated by insulin, catecholamines, acid-base status</li>\n<li><strong>Total body K elimination:</strong> By kidney(95%) and gut (5%)</li>\n</ul>\n<h2 id=\"adverse-effects-of-hyperkalemia\">Adverse effects of hyperkalemia</h2>\n<ul>\n<li><strong>Cardiac:</strong> Peaked T, wide QRS, loss of P wave, sine wave; although V fib may be first cardiac manifestation.</li>\n<li><strong>Neuromuscular:</strong> Paresthesias,weakness</li>\n<li><strong>Metabolic:</strong> Mild hyperchloremic metabolic acidosis</li>\n</ul>\n<h2 id=\"treatment-of-hyperkalemia\">Treatment of hyperkalemia</h2>\n<p><strong>Cardiac membrane stabilization </strong></p>\n<ul>\n<li><strong>Calcium:</strong> Reduces threshold potential in myocytes; check to be sure not on digoxin</li>\n<li><p><strong>Hypertonic saline:</strong> Only for severe hyponatremia in setting of hyperkalemia</p>\n<p><strong>K redistribution</strong></p>\n</li>\n<li><strong>Insulin:</strong> Drives K intracellularly and drops serum K level by 0.6 mmol/L</li>\n<li><strong>Beta-agonist:</strong> Drives K intracellularly and 10 mg albuterol drops serum K level by 0.6 mmol/L(20 mg --&gt; K drops by 1 mmol/L);effective in only 60% of patients</li>\n</ul>\n<p><strong> K elimination via kidney/gut</strong></p>\n<ul>\n<li><strong>Bicarbonate:</strong> drives K out at distal nephron; best as infusion x 4-6 hrs</li>\n<li><strong>Loop diuretic</strong></li>\n<li><strong>Exchange resin</strong> (sodium polystyrene sulfonate): case reports of colonic necrosis;constipating med and so combined with sorbitol; minimal benefit. </li>\n</ul>\n<table>\n  <tr>\n    <th>Agent</th>\n    <th>Dose</th>\n    <th>Onset</th>\n    <th>Duration</th>\n    <th>Complication</th>\n  </tr>\n  <tr>\n    <td colspan=\"5\"><strong>Membrane Stabilization</strong></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Ca gluconate 10%</span></td>\n    <td>10 mL over 10 min</td>\n    <td>immediate</td>\n    <td>30-60min</td>\n    <td>hypercalcemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hypertonic 3% NaCl</span></td>\n    <td>50cc IV push</td>\n    <td>immediate</td>\n    <td>unknown</td>\n    <td>volume overload, hypertonicity</td>\n  </tr>\n  <tr>\n    <td colspan=\"5\"><strong>Redistribution</strong></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Insulin</span></td>\n    <td>10 units IVP with D50W</td>\n    <td>20 min</td>\n    <td>4-6 hr</td>\n    <td>hypoglycemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Albuterol nebulized</span></td>\n    <td>20mg/4cc over 10 min</td>\n    <td>30 min</td>\n    <td>2 hrs</td>\n    <td>tachycardia</td>\n  </tr>\n  <tr>\n    <td colspan=\"5\"><strong>Elimination</strong></td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Loop diuretic</span></td>\n    <td>furosemide 40-80 mg IV</td>\n    <td>15 min</td>\n    <td>2-3 hr</td>\n    <td>volume depletion</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Sodium bicarbonate</span></td>\n    <td>150 mmol/L IV</td>\n    <td>hours</td>\n    <td>infusion</td>\n    <td>metabolic alkalosis, volume overload</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Kayexalate</span></td>\n    <td>150-30 g</td>\n    <td>&gt;2 hrs</td>\n    <td>4-6 hr</td>\n    <td>variable efficacy</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hemodialysis</span></td>\n    <td></td>\n    <td>immediate</td>\n    <td>3 hrs</td>\n    <td>arrhythmias</td>\n  </tr>\n</table>\n\n\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=18936701\">Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008; 36:3246-51.</a></li>\n</ul>\n"}}